Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Shares, No Par Value
-
Shares outstanding
-
28,495,649
-
Total 13F shares
-
1,582,033
-
Share change
-
-76,592
-
Total reported value
-
$5,632,178
-
Price per share
-
$3.56
-
Number of holders
-
24
-
Value change
-
-$394,497
-
Number of buys
-
10
-
Number of sells
-
20
Institutional Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX) as of Q2 2016
As of 30 Jun 2016,
Oncocyte Corporation - Common Shares, No Par Value (OCX) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,582,033 shares.
The largest 10 holders included
BROADWOOD CAPITAL INC, BRIDGEWAY CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., Manatuck Hill Partners, LLC, Artal Group S.A., GOLDMAN SACHS GROUP INC, Destination Wealth Management, GEODE CAPITAL MANAGEMENT, LLC, and Paloma Partners Management Co.
This page lists
24
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.